Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS.

Annales d'endocrinologie - 1 Feb 2024

Mitra Subarna, Saharia Gautom K, Jena Saubhagya K

Abstract excerpt

BACKGROUND AND AIMS: Elevated anti-Müllerian hormone (AMH) in polycystic ovary syndrome (PCOS) characterizes the clinical severity of the 4 phenotypes; but whether it also reflects the corresponding differences in cardio-metabolic risk remains to be elucidated. This study aimed to compare metabolic profile between the 4 clinical phenotypes of PCOS and to determine the influence of AMH levels on metabolic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Mullerian Hormone
Share to Cross-Sectional Studies
Share to Insulin Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metabolic Syndrome

Share to Phenotype

Share to Polycystic Ovary Syndrome

Share to Young Adult

Source

Identifiers

PMID: 37328054
DOI: 10.1016/j.ando.2023.06.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS.PMID 37328054Read ↗

Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.Semantic proximity Read ↗

Cardiometabolic Markers and Serum Amh Levels in Pcos: Can Amh Serve as a Surrogate Cardiometabolic Marker?Semantic proximity Read ↗

Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes.Semantic proximity Read ↗

Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.Semantic proximity Read ↗

Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteriaSemantic proximity Read ↗

Prevalence of metabolic syndrome among women with different PCOS phenotypes - a prospective study.Semantic proximity Read ↗

Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.Semantic proximity Read ↗

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.Semantic proximity Read ↗

The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.Semantic proximity Read ↗

Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes – a cross-sectional studySemantic proximity Read ↗

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?Semantic proximity Read ↗

Metabolic risk in PCOS: phenotype and adiposity impact.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.